-
The Cochrane Neuromuscular Group is looking to appoint one or more new Co-ordinating Editor(s) to provide leadership of the Group. The Cochrane Neuromuscular Group is part of the Cochrane Mental Health and Neuroscience Network. This is an important opportunity to lead and shape the future development of a strategically important area of Cochrane’s...
15 January 2021
-
Pharmacological interventions for self‐harm in adults
Cochrane authors have reviewed the international literature regarding pharmacological (drug) and natural product (dietary supplementation) treatment trials in the field. A total of seven trials that met inclusion criteria were identified. There is little evidence of beneficial effects of either...
14 January 2021
-
Many experts published their opinions about the impact of COVID-19 on rehabilitation early on, but none were based on real-world experience. Cochrane Rehabilitation wanted to share information rapidly as it emerged so rehabilitation services and patients around the world would know how the pandemic might affect them.
Since March 2020, Cochrane...
14 January 2021
-
Cochrane provides high-quality, relevant and up-to-date synthesized research evidence to inform health decisions. This page highlights the many ways that Cochrane has successfully responded to COVID-19 around the world. Click on any of the case studies below to find out more, and check back often as we continuously add and update new stories....
14 January 2021
-
During the COVID-19 pandemic, people relied on research evidence to help make decisions that affected the health of millions. Cochrane had the skills and experience to draw together the research evidence. We needed to work more quickly than our usual systematic review process, which sometimes takes many months to search widely and assess research...
13 January 2021
-
At the start of the COVID-19 pandemic, many countries implemented lockdowns or stay-at-home orders. Most dental services provided only emergency treatment so patients and dental professionals could stay safe. This left many people in pain or without access to care. As countries began to ease their lockdown restrictions, policy-makers and dental...
12 January 2021
-
'Let's talk e-cigarettes'' is a podcast talking about the latest research on e-cigarettes and how new research changes what we know about them. It's hosted by Cochrane Tobacco Addiction researchers Dr Jamie Hartmann-Boyce and Dr Nicola Lindson based at the University of Oxford, through funding from Cancer Research UK. You can listen to the podcast...
12 January 2021
-
The Early Career Professionals group aims to provide its members with opportunities to enhance their knowledge, skills, and expertise by providing a platform for international networking with early career professionals or other members in the Cochrane community.
Though there is no one single definition of an ‘Early Career Professional/Researcher...
11 January 2021
-
It’s hard to stay up-to-date with the latest health evidence. Listen to leading experts and Cochrane review authors explain in plain language the evidence and findings of their high-impact reviews. In 5 minutes or less, healthcare professionals to patients and families can understand the latest trusted evidence to help make better informed...
11 January 2021
-
Decision-makers are making decisions about COVID-19 that affect the health of millions of people. Researchers have been quick to do studies about COVID-19, but it can be difficult to stay up to date. Cochrane France wanted to bring together the global evidence about preventing, treating and rehabilitating people with COVID-19 regularly and in one...
8 January 2021
-
The new Chilean Satellite of the Cochrane Effective Practice of Care (EPOC) Review Group works with the Ministry of Health to help inform decisions.
In April 2020, the Chilean Satellite of Cochrane EPOC contacted the Department of Health Technology Assessment and Evidence Based Health in the Chilean Ministry of Health (HTA). They knew...
8 January 2021
-
What is the best way to support resilience and mental well-being in frontline healthcare professionals during and after a pandemic? What is ‘resilience’?
Updated Jan 2021: Listen to lead author Alex Pollock from Glasgow Caledonian University in Scotland explain what the review found.
Updated Dec 2020: new brief for health systems planners and...
8 January 2021
-
Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes.
...
8 January 2021
-
There were no prevention or treatment protocols in place when COVID-19 reached South Africa. Policy-makers needed to work rapidly to support our diverse communities. There were thousands of studies emerging from around the world, but there was a lot of duplication, variable quality and sometimes contradictory findings. The South African (SA)...
7 January 2021
-
Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals.
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA...
7 January 2021
-
Behavioural interventions for smoking cessation: an overview and network meta‐analysis
Key messages
Behavioural support can help more people to stop smoking for six months or longer, without causing unwanted effects.
Some types of support appear to work better than others. More studies are needed to identify the best ways to support...
5 January 2021
-
In this short interview, PhD student Camilla Hansen Nejstgaard, from Cochrane Denmark and Centre for Evidence-Based Medicine Odense (CEBMO) at the University of Southern Denmark, tells us about how conflicts of interest may impact on recommendations of drugs and medical devices. She is the lead author of a recently published Cochrane Methodology...
5 January 2021
-
Cochrane Sweden, in collaboration with TranspariMED, recently published a report on clinical trial transparency in Sweden.
The report draws on data from the EU Trials Tracker and summarises the current extent of clinical drug trial reporting for different organisations in Sweden. Under the European Commission’s Clinical Trial Regulation, clinical...
29 December 2020
-
The Cochrane review about antenatal steroids for reducing risk of infant mortality and morbidity is an important one in Cochrane's history. Cochrane's logo is based on the forest plot from an early version of this review dating back to 1982. This review has recently been updated and lead author, Fiona Stewart, tells us how the logo might look now...
29 December 2020
-
Dr. Karla Soares-Weiser, Editor in Chief of the Cochrane Library, presented at Brigham and Women's Hospital Surgical Grand Rounds on December 2, 2020, as part of the Professional Fulfillment Virtual Series. In the presentation, titled "Leadership, systematic reviews, and COVID: An international perspective", Dr. Soares-Weiser reflected on her...
29 December 2020
The Cochrane Neuromuscular Group is looking to appoint one or more new Co-ordinating Editor(s) to provide leadership of the Group. The Cochrane Neuromuscular Group is part of the Cochrane Mental Health and Neuroscience Network. This is an important opportunity to lead and shape the future development of a strategically important area of Cochrane’s...15 January 2021
Pharmacological interventions for self‐harm in adults Cochrane authors have reviewed the international literature regarding pharmacological (drug) and natural product (dietary supplementation) treatment trials in the field. A total of seven trials that met inclusion criteria were identified. There is little evidence of beneficial effects of either...14 January 2021
Many experts published their opinions about the impact of COVID-19 on rehabilitation early on, but none were based on real-world experience. Cochrane Rehabilitation wanted to share information rapidly as it emerged so rehabilitation services and patients around the world would know how the pandemic might affect them. Since March 2020, Cochrane...14 January 2021
Cochrane provides high-quality, relevant and up-to-date synthesized research evidence to inform health decisions. This page highlights the many ways that Cochrane has successfully responded to COVID-19 around the world. Click on any of the case studies below to find out more, and check back often as we continuously add and update new stories....14 January 2021
During the COVID-19 pandemic, people relied on research evidence to help make decisions that affected the health of millions. Cochrane had the skills and experience to draw together the research evidence. We needed to work more quickly than our usual systematic review process, which sometimes takes many months to search widely and assess research...13 January 2021
At the start of the COVID-19 pandemic, many countries implemented lockdowns or stay-at-home orders. Most dental services provided only emergency treatment so patients and dental professionals could stay safe. This left many people in pain or without access to care. As countries began to ease their lockdown restrictions, policy-makers and dental...12 January 2021
'Let's talk e-cigarettes'' is a podcast talking about the latest research on e-cigarettes and how new research changes what we know about them. It's hosted by Cochrane Tobacco Addiction researchers Dr Jamie Hartmann-Boyce and Dr Nicola Lindson based at the University of Oxford, through funding from Cancer Research UK. You can listen to the podcast...12 January 2021
The Early Career Professionals group aims to provide its members with opportunities to enhance their knowledge, skills, and expertise by providing a platform for international networking with early career professionals or other members in the Cochrane community. Though there is no one single definition of an ‘Early Career Professional/Researcher...11 January 2021
It’s hard to stay up-to-date with the latest health evidence. Listen to leading experts and Cochrane review authors explain in plain language the evidence and findings of their high-impact reviews. In 5 minutes or less, healthcare professionals to patients and families can understand the latest trusted evidence to help make better informed...11 January 2021
Decision-makers are making decisions about COVID-19 that affect the health of millions of people. Researchers have been quick to do studies about COVID-19, but it can be difficult to stay up to date. Cochrane France wanted to bring together the global evidence about preventing, treating and rehabilitating people with COVID-19 regularly and in one...8 January 2021
The new Chilean Satellite of the Cochrane Effective Practice of Care (EPOC) Review Group works with the Ministry of Health to help inform decisions.
What is the best way to support resilience and mental well-being in frontline healthcare professionals during and after a pandemic? What is ‘resilience’? Updated Jan 2021: Listen to lead author Alex Pollock from Glasgow Caledonian University in Scotland explain what the review found. Updated Dec 2020: new brief for health systems planners and...8 January 2021
Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes. ...8 January 2021
There were no prevention or treatment protocols in place when COVID-19 reached South Africa. Policy-makers needed to work rapidly to support our diverse communities. There were thousands of studies emerging from around the world, but there was a lot of duplication, variable quality and sometimes contradictory findings. The South African (SA)...7 January 2021
Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals. Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA...7 January 2021
Behavioural interventions for smoking cessation: an overview and network meta‐analysis
In this short interview, PhD student Camilla Hansen Nejstgaard, from Cochrane Denmark and Centre for Evidence-Based Medicine Odense (CEBMO) at the University of Southern Denmark, tells us about how conflicts of interest may impact on recommendations of drugs and medical devices. She is the lead author of a recently published Cochrane Methodology...5 January 2021
Cochrane Sweden, in collaboration with TranspariMED, recently published a report on clinical trial transparency in Sweden. The report draws on data from the EU Trials Tracker and summarises the current extent of clinical drug trial reporting for different organisations in Sweden. Under the European Commission’s Clinical Trial Regulation, clinical...29 December 2020
The Cochrane review about antenatal steroids for reducing risk of infant mortality and morbidity is an important one in Cochrane's history. Cochrane's logo is based on the forest plot from an early version of this review dating back to 1982. This review has recently been updated and lead author, Fiona Stewart, tells us how the logo might look now...29 December 2020
Dr. Karla Soares-Weiser, Editor in Chief of the Cochrane Library, presented at Brigham and Women's Hospital Surgical Grand Rounds on December 2, 2020, as part of the Professional Fulfillment Virtual Series. In the presentation, titled "Leadership, systematic reviews, and COVID: An international perspective", Dr. Soares-Weiser reflected on her...29 December 2020